Dr. med. Tobias R. Overbeck

Name Card

Main Affiliation
 
Staff Status
unigoe
 

1-14 of 14
 
The bibliographical data in your publication list are complete
You can correct existing data in the blue highlighted fields.To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
The bibliographic data in your publication list may be incomplete. You can
  • add any missing data in the fields marked in red or
  • correct existing data in the blue highlighted fields.
To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
Check/Uncheck all
  • 2023 | Journal Article | Research Paper | 
    ​ ​Social participation during the COVID-19 pandemic in persons with a high risk for a severe course of COVID-19 – results of a longitudinal, multi-center observational study in Germany​
    Schröder, D. ; Müllenmeister, C.; Heinemann, S. ; Hummers, E. ; Klawonn, F.; Vahldiek, K. & Dopfer-Jablonka, A. et al.​ (2023) 
    Health Psychology and Behavioral Medicine, 11(1).​ DOI: https://doi.org/10.1080/21642850.2023.2249534 
    ​Details  DOI 
  • 2022 | Journal Article | Research Paper | 
    ​ ​“SpezPat”- common advance directives versus disease-centred advance directives: a randomised controlled pilot study on the impact on physicians’ understanding of non-small cell lung cancer patients’ end-of-life decisions​
    Koenig, J. F. L.; Asendorf, T. ; Simon, A. ; Bleckmann, A. ; Trümper, L. ; Wulf, G. G.   & Overbeck, T. R. ​ (2022) 
    BMC Palliative Care, 21(1) art. 167​.​ DOI: https://doi.org/10.1186/s12904-022-01057-5 
    ​Details  DOI 
  • 2022 | Journal Article | Research Paper
    ​ ​SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study​
    Dopfer-Jablonka, A.; Steffens, S.; Müller, F. ; Mikuteit, M.; Niewolik, J.; Cossmann, A. & Stankov, M. V. et al.​ (2022) 
    BMC Infectious Diseases, 22(1) art. 403​.​ DOI: https://doi.org/10.1186/s12879-022-07347-w 
    ​Details  DOI  PMID  PMC 
  • 2022 | Journal Article
    ​ ​NSCLC with uncommon EGFR mutations treated with atezolizumab plus bevacizumab and chemotherapy​
    Trummer, A.; Bethge, A.; Dickgreber, N.; Dittrich, I.; Golpon, H.; Hoffknecht, P. & Overbeck, T. R.  et al.​ (2022) 
    Lung Cancer, 174 pp. 141​-145​.​ DOI: https://doi.org/10.1016/j.lungcan.2022.11.006 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​Capmatinib in MET Exon 14–Mutated or MET -Amplified Non–Small-Cell Lung Cancer​
    Wolf, J.; Seto, T.; Han, J.-Y.; Reguart, N.; Garon, E. B.; Groen, H. J. & Tan, D. S. et al.​ (2020) 
    New England Journal of Medicine, 383(10) pp. 944​-957​.​ DOI: https://doi.org/10.1056/NEJMoa2002787 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials​
    Doebele, R. C; Drilon, A.; Paz-Ares, L.; Siena, S.; Shaw, A. T; Farago, A. F & Blakely, C. M et al.​ (2020) 
    The Lancet Oncology, 21(2) pp. 271​-282​.​ DOI: https://doi.org/10.1016/S1470-2045(19)30691-6 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Leucaemia cutis bei einem Patienten mit chronischer myelomonozytärer Leukämie​
    Claßen, A.; Kitz, J. ; Perske, C. ; Overbeck, T. ; Bertsch, H. P. ; Schön, M. P.   & Lippert, U. ​ (2018) 
    JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 16(1) pp. 82​-84​.​ DOI: https://doi.org/10.1111/ddg.13398_g 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​PS04.06 GEOMETRY Mono-1: Phase II, Multicenter Study of MET Inhibitor Capmatinib (INC280) in EGFR wt, MET-dysregulated Advanced NSCLC​
    Wolf, J.; Han, J.; Nishio, M.; Souquet, P.; Paz-Ares, L.; De Marinis, F. & Seto, T. et al.​ (2017) 
    Journal of Thoracic Oncology, 12(11) pp. S1578​-S1579​.​ DOI: https://doi.org/10.1016/j.jtho.2017.09.075 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​P2.04-005 GEOMETRY Mono-1: Phase II, Multicenter Study of MET Inhibitor Capmatinib (INC280) in EGFR Wt, MET-Dysregulated Advanced NSCLC​
    Wolf, J.; Han, J.; Nishio, M.; Souquet, P.; Paz-Ares, L.; De Marinis, F. & Seto, T. et al.​ (2017) 
    Journal of Thoracic Oncology, 12(11) pp. S2399​.​ DOI: https://doi.org/10.1016/j.jtho.2017.11.018 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Leukemia cutis in a patient with chronic myelomonocytic leukemia​
    Claßen, A.; Kitz, J. ; Perske, C. ; Overbeck, T. ; Bertsch, H. P. ; Schön, M. P.   & Lippert, U. ​ (2017) 
    Journal der Deutschen Dermatologischen Gesellschaft, 16(1) pp. 81​-83​.​ DOI: https://doi.org/10.1111/ddg.13398 
    ​Details  DOI 
  • 2017 | Journal Article | 
    ​ ​ABCA3 Phenotype in Non-Small Cell Lung Cancer Indicates Poor Outcome​
    Overbeck, T. R. ; Arnemann, J. ; Waldmann-Beushausen, R. ; Schöndube, F. A. ; Reuter-Jessen, K. ; Danner, B. C.   & Trümper, L.​ (2017) 
    Oncology, 93(4) pp. 270​-278​.​ DOI: https://doi.org/10.1159/000477619 
    ​Details  DOI  PMID  PMC 
  • 2016 | Journal Article | Research Paper | 
    ​ ​Partielles Ansprechen auf Crizotinib als Erstlinientherapie bei einem älteren männlichen Patienten mit ROS1-Translokations-positivem Bronchialkarzinom​
    Overbeck, T. R. ; Schmitz, K.; Engelke, C.; Sahlmann, C.-O. ; Hugo, S.; Kellner, L. & Trümper, L.  et al.​ (2016) 
    Karger-Kompass Onkologie, 3(2) pp. 97​-100​.​ DOI: https://doi.org/10.1159/000449192 
    ​Details  DOI 
  • 2016 | Journal Article
    ​ ​Partial Response to First-Line Crizotinib in an Elderly Male Patient with ROS1 Translocation-Positive Lung Cancer​
    Overbeck, T. R. ; Schmitz, K.; Engelke, C.; Sahlmann, C.-O. ; Hugo, S.; Kellner, L. & Trümper, L.  et al.​ (2016) 
    Case Reports in Oncology, 9(1) pp. 158​-163​.​ DOI: https://doi.org/10.1159/000444745 
    ​Details  DOI 
  • 2009 | Journal Article | 
    ​ ​Toxicity of daily low dose cisplatin in radiochemotherapy for locally advanced head and neck cancer​
    Wolff, H. A. ; Overbeck, T. R. ; Roedel, R. M. W.; Hermann, R. M.; Herrmann, M. K. A.; Kertesz, T. & Vorwerk, H. et al.​ (2009) 
    Journal of Cancer Research and Clinical Oncology, 135(7) pp. 961​-967​.​ DOI: https://doi.org/10.1007/s00432-008-0532-x 
    ​Details  DOI  PMID  PMC  WoS 

Publication List

All Articles (Book & Journal) Articles & Preprints Papers (Journal & Conference)

Type

Subtype

Date issued

Author

Project

Peer-Reviewed

Organization

Language

Fulltext

Options

Citation Style

GRO View APA Chicago MLA Vancouver
https://publications.goettingen-research-online.de URI: /cris/rp/rp34992
ID: 0000000
PREF: default TOKEN:

0

Sort

Issue Date
ASC DESC
Title
ASC DESC

Embed

JavaScript
Link

Export

Activate Export Mode
Deactivate Export Mode

Select some or all items (max. 800 for CSV/Excel) from the publications list, then choose an export format below.